Pharmaceuticals & Biotechnology

By Jim Sabogal | Using #clinicaltrials to make #medicines for #pharma and #biotech

Avoiding Counterfeit Pills in the Age of Big Pharma

Chris Crepeau couldn't understand why he felt the way he did.<p>As usual, the New Jersey man took his daily dose of Lipitor for high cholesterol. Still, …

Philadelphia

Cancer drug shows unexpected fat-melting side effects

A drug developed originally to treat breast cancer and diabetes has been found to offer an unexpected and beneficial side effect. Scientists have …

Medicine

The Precision Medicine Stock That's Revolutionizing Cancer Treatment

Cancer treatment is moving rapidly toward personalized medicine and precision medicine thanks to genetic insight.<p><b>Foundation Medicine</b>'s (NASDAQ:FMI) …

Stocks

Gene editing remains early stage, but Big Pharma has taken notice

Gene editing offers near-limitless medical potential. The challenge is putting it into medical practice. So how is gene editing progressing, in terms …

Medical Technology

Innovating at the speed of the 21st century in pharmaceuticals

The CEO of Eli Lilly offers perspectives on accelerating change in the industry.<p><i>Eli Lilly and Company is an innovation-driven biopharmaceutical</i> …

Innovation

More evidence emerges for Amazon's push into pharmacy industry

The e-commerce giant has obtained pharmaceutical distribution licenses in 12 US states.<p>New evidence emerged Friday that Amazon may have its sights set on the drug industry.<p>According to public records dug up by the St. Louis Post-Dispatch, Amazon has obtained approval to be a wholesale distributor …

Amazon

CRO Consolidation: A Sinister Threat Or Windfall For Pharma?

The drug development process is fraught with complexities and challenges, with delays and cost overruns being a commonplace occurrence. In-human clinical trials represent the final endgate satisfying regulatory agency concerns over efficacy and safety while being the costliest phase of bringing a …

Digital Health

FDA Approves Another Amazing And Costly Cancer-Killing Gene Therapy

In 2010, Josh Feldman was on his honeymoon — a globe-spanning trip that at one point involved swimming with humpback whales — when he noticed a “Garbanzo-sized” lump on the back of his neck. It turned out to be lymphoma, which worsened even as he cycled through treatments: chemotherapy, the …

Cancer

Tiny Ignyta's Lung Cancer Drug Bested Pfizer's. Probably. Will We Ever Know For Sure?

There should have been a drug to prolong Stuart Brown’s life. But when his first option failed him, it seemed there was nothing else to try.<p>Then came a drug made by Ignyta Pharmaceuticals, a San Diego-based drugmaker, that shrank his tumors and has kept them in check for more than a year. Results …

Cancer

Doctors With Strong Financial Ties To Pharma Are Found More Likely To Prescribe Brand-Name Drugs

Generic cholesterol pills are probably better for most patients than brand-name medications because the lower cost of generics increases the chance the patients will take the pills every day.<p>Yet some physicians primarily prescribe expensive brand-name drugs like Lipitor and Crestor. According to a …

Pharma

Viruses discovered a century ago may be our best defense against a threat that could kill 10 million people a year by 2050

Antibiotic resistance — the phenomenon in which bacteria stop responding to certain antibiotics — is a growing threat around the world.<p>It's expected to kill 10 million people annually by 2050.<p>And it hasn't been easy to develop new drugs in order to stay ahead of the problem. Many major …

Medicine

Biotech, Brexit and big data: Nathalie Moll on the state of Europe’s pharma industry

Nathalie Moll is the newly appointed director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), assuming the …

Pharma

A biotech backed by Bill Gates is developing therapies that could treat everything from skin diseases to cancer

A Chicago-based biotech that's backed by Bill Gates wants to build treatments that can silence genes to treat diseases like cancer.<p>In September, Exicure, led by 36-year-old David Giljohann, raised $20 million from investors including Gates, AbbVie Ventures, Groupon cofounder Eric Lefkofsky, and …

Medicine

Big Pharma Creating Startup Firms to Do Drug Research

Pharmaceutical companies are trying to capture a little bit of the startup magic.<p>Pfizer and several other firms have invested in a small spinoff …

Pharma

3 Big Pharma Stocks Set to Succeed

Solid current franchises and strong pipelines could make these three big pharma stocks big winners in coming years.<p>That disclaimer that the …

Stocks

We have a cure for hepatitis C. But the neediest can’t afford it. Louisiana wants to change that.

An innovative solution to the high cost of prescription drugs is emerging in one of the unlikeliest places: Louisiana’s state government.<p>The Louisiana health secretary, Dr. Rebekah Gee, has called attention to the plight of tens of thousands of state residents suffering from infection with the …

Pharma

Absent Federal Action, States Take The Lead On Curbing Drug Costs

<i>Updated, 12:26 p.m. This story was updated to reflect that a federal judge rejected a request to block the Maryland law from going forward.</i><p>Lawmakers …

Health Care

The 20 top-selling prescription drugs

Humira, the blockbuster anti-inflammatory drug that is routinely blasted on TV commercials, netted $13.6 billion in gross U.S. sales last year — the …

A startup spun out of Pfizer just got $103 million to develop experimental drugs Big Pharma won't

There's a popular theory about the limitations of global pharma companies: For all their skyscrapers and strategy reviews and private jets, they're simply too knotted up in bureaucracy to realize how many great drugs are gathering dust in their vaults.<p>Now, the biggest of Big Pharma is out do do …

Startups

Soon your infection could be untreatable with antibiotics, World Health Organization report says

A report published Tuesday by the World Health Organization (WHO) suggests the world may soon run out of effective antibiotics.<p>According to the …

Medicine

Pfizer leads Big Pharma's emerging markets growth as GlaxoSmithKline, Eli Lilly lag

Big Pharma’s businesses in emerging markets grew 6.1% sequentially in the second quarter, the fastest in more than two years, according to a recent …

This Startup Is Bringing a $40 Billion Market Out of the Stone Age

This paper-based industry is long overdue for a digital overhaul.<p>While much of the research and development conducted by the global pharmaceutical industry relies on cutting edge technology, one aspect of the process of developing and testing new drugs is decidedly low tech: clinical …

Alexion's Growth Appears Dead

ALXN announced it was restructuring its business and moving its headquarters from New Haven, CT to Boston.<p>Sales in the second half of 2017 could …

Why Amgen, Lilly, J&J Are Interested In These Small Biotechs

<b>Theravance Biopharma</b> (TBPH) and <b>Exelixis</b> (EXEL) tick off most of the acquisition boxes for Big Pharma in an overview of the biotech merger picture, an …

The Biotech Revolution Comes To Fruition For Investors

It took well over a decade and $1 billion to map the first genome. Now, it can be done in a few days for a few thousand dollars. As a result, entirely new classes of drugs are under development to combat a variety of diseases for which no effective treatments exist. A revolution in biotech is …

Stocks

Why Drugs Cost Less in the U.K. Than in the U.S.

Drug prices in the U.K., already among the lowest in the developed world, may drop lower still. The British public-health system has adopted new …

Pharma

How To Improve Precision Medicine With Machine Learning

This column is authored by Computer Science student, Awais Ali<p>Photo by Hal Gatewood on Unsplash<p>Machine learning can be the difference between life …

A Serious Reaction After Vaccination Rarely Occurs Again With Later Immunization, Study Finds

A child who experiences a serious medical event after a vaccine has a very low risk of having another serious event occur after the next vaccine, found a new study. Milder reactions, such as fevers, swelling, pain, sleepiness, decreased appetite, vomiting or persistent crying, re-occurred in 4% to …

Medicine

A first: Drug lowers heart risks by curbing inflammation

For the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol, the focus for many years.<p>People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an …